SOHO 2024

View a collection of content focus on chronic lymphocytic leukemia, as presented at the Society of Hematologic Oncology Meeting 2024, taking place September 4-7, 2024.

Cytogenetic Anomaly Screening is Necessary in CLL Patients Before Treatment
Cytogenetic Anomaly Screening is Necessary in CLL Patients Before Treatment
Rob DillardSOHO 2024: Focus on CLL | September 12, 2024
Cytogenic anomaly screening should be performed in every patient with CLL.
CD200 is an Effective Marker for Patients With Atypical CLL
CD200 is an Effective Marker for Patients With Atypical CLL
Rob DillardSOHO 2024: Focus on CLL | September 12, 2024
A study finds that CD200 is an effective diagnostic marker in atypical chronic lymphocytic leukemia.
Identification and Diagnosis of Possible Mutations in Human p53 Lymphocytes in Patients With B-cell CLL
Identification and Diagnosis of Possible Mutations in Human p53 Lymphocytes in Patients With B-cell CLL
Rob DillardSOHO 2024: Focus on CLL | September 12, 2024
For patients with B-cell CLL, a simple method is effective at identifying patients eligible for personalized therapies.
Oral Targeted Inhibitors Effective for CLL Patients With Severe Renal Dysfunction
Oral Targeted Inhibitors Effective for CLL Patients With Severe Renal Dysfunction
Rob DillardOncology | September 12, 2024
Oral target inhibitors are a viable treatment option for CLL patients with serve renal dysfunction.
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Contact Us

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |